The vaccine 'Covaxin' is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). ...
Related News
COVID-19 vaccine update: DGCI panel gives nod to phase 3 trials of Bharat Biotech's Covaxin
In another major update for coronavirus vaccine in India, Covaxin - the drug developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical...
DNA India 2020-10-23DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine
The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III...
Mid Day 2020-10-23Bharat Biotech's COVID-19 vaccine Covaxin gets approval for phase 3 trials
New Delhi, Oct 22: Covaxin, an indigenously developed vaccine candidate by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has got...
One India 2020-10-22Covaxin, Bharat Biotech's coronavirus vaccine, gets DCGI approval to conduct phase 3 clinical trials
Leading vaccine maker Bharat Biotech, which is developing India's own vaccine for coronavirus named COVAXIN has got the nod from the Drugs Controller General of India...
India TV 2020-10-22Covaxin: Bharat Biotech to conduct Phase-3 clinical trials in 26,000 volunteers
Bharat Biotech, a leading vaccine maker which�is developing India's own vaccine for coronavirus named COVAXIN�said it has successfully completed interim analysis of Phase I...
India TV 2020-10-23Covid-19 vaccine: Bharat Biotech to conduct Phase-3 trials in 26,000 volunteers
HYDERABAD: Bharat Biotech, which is into developing Covaxin, a vaccine candidate for Covid-19, on Friday said it has successfully completed interim analysis of Phase I and...
The Times of India 2020-10-23Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase...
NDTV 2020-10-22